You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Hereditary Cancers Guideline: An Endorsement of the 2015 Standards and Guidelines for the Interpretation of Sequence Variants

Guideline Objective

The Molecular Oncology and Testing Advisory Committee of Cancer Care Ontario endorses the recommendations of Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, published by the American College of Medical Genetics and Genomics (ACMG) regarding inherited cancers, as modified by the endorsement process described in this document.

This endorsement project was sponsored by MOTAC. The endorsed guideline will be used for the interpretation of sequence variants.

Intended Guideline Users

This guideline is intended for molecular geneticists, clinical geneticists, molecular pathologists and genetic counsellors across the province.

Modality: 

Pathology and Laboratory Testing

PEBC: 

PEBC

Guideline Identifier: 

GL-END MOTAC 5

Cancer Continuum: 

Diagnosis

Cancer Type: 

All

Type of Content: 

Guidelines & Advice

Clinical

Authors:  H. Feilotter D. Sivajohanathan T. Graham V.M. Siu M. Speevak T. Stockley Molecular Oncology and Testing Advisory Committee Universal Date:  2017-08-02 00:00:00